US drugmaker Pfizer Inc (NYSE:PFE) on Monday abandoned its pursuit to buy AstraZeneca PLC, saying it does not plan to make an offer for the British drugmaker following the rejection of its final proposal last week. Pfizer Inc. (NYSE:PFE) stock performance was -0.57% in last session and finished the day at $29.49. Traded volume was…
On Friday, Inovio Pharmaceuticals Inc (NYSEMKT:INO) announced that its shareholders had approved 1-for-4 reverse stock split of company common stock. Company shares sank more than 5% in morning trading. The company said that the effective date of the reverse stock split would be disclosed at a future date after The company complies with “standard NYSE…
RetailMeNot Inc (NASDAQ:SALE) SVP Jagjit Bath sold 2,500 shares of the stock on the open market in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $29.75, for a total transaction of $74,375.00. Following the completion of the sale, the senior vice president now directly owns 30,000 shares in…
salesforce.com, inc. (NYSE:CRM), the biggest maker of customer-management software, forecast second-quarter sales that exceeded analysts’ predictions as the company’s Web-based products continue to lure new users. Revenue in the quarter ending in July will be about $1.29 billion, the San Francisco-based company said yesterday in a statement. salesforce.com, inc. (NYSE:CRM) stock performance was -5.10% in…
Inovio Pharmaceuticals (NYSE:INO)’s shares were the target of a large decline in short interest in April. As of April 15th, there was short interest totalling 28,830,223 shares, a decline of 2.1% from the March 31st total of 28,233,502 shares, Analyst Ratings News reports.Inovio Pharmaceuticals Inc (NYSEMKT:INO)stock performance was -6.25% in last session and finished the…
Inovio Pharmaceuticals Inc (NYSE:INO) CEO Jong Joseph Kim bought 25,000 shares of the company’s stock in a transaction dated Tuesday, April 15th. The shares were purchased at an average price of $2.25 per share, for a total transaction of $56,250.00. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was -2.62% in last session and finished the day…
